Get the Stockscreener App
0.3138
17.77%
-0.0678
Enzo Biochem Inc stock is traded at $0.3138, with a volume of 4.12M.
It is down -17.77% in the last 24 hours and up +0.00% over the past month.
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.
See More
Previous Close:
$0.3816
Open:
$0.3702
24h Volume:
4.12M
Relative Volume:
14.51
Market Cap:
$31.65M
Revenue:
$30.31M
Net Income/Loss:
$-22.84M
P/E Ratio:
-0.6973
EPS:
-0.45
Net Cash Flow:
$-22.61M
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
-53.85%
1Y Performance:
-71.73%
1-Day Range:
$0.3138
$0.40
1-Week Range:
$0.3138
$0.40
52-Week Range:
$0.252
$1.20
Enzo Biochem Inc Stock (ENZ) Company Profile
Name
Enzo Biochem Inc
Sector
Industry
Phone
(516) 755-5500
Address
60 EXECUTIVE BLVD, FARMINGDALE, NY
Compare ENZ with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENZ
Enzo Biochem Inc
|
0.3138 | 31.65M | 30.31M | -22.84M | -22.61M | -0.45 |
|
TMO
Thermo Fisher Scientific Inc
|
434.86 | 156.49B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
204.85 | 145.01B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
533.37 | 42.30B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
123.28 | 34.24B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
162.80 | 27.64B | 15.50B | 1.33B | 2.16B | 7.34 |
Enzo Biochem Inc Stock (ENZ) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-18-11 | Reiterated | Rodman & Renshaw | Mkt Outperform |
| Sep-23-09 | Initiated | Rodman & Renshaw | Mkt Outperform |
| Sep-13-07 | Initiated | Lazard Capital | Buy |
Enzo Biochem Inc Stock (ENZ) Latest News
Investigation into Hudson Global, Enzo Biochem, and Breeze Holdings mergers by Monteverde & Associates PC. - AInvest
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: DNOW, ENZB, SPTN, and BASE - cnhinews.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CARM, ENZB, GNTY on Behalf of Shareholders - MarketScreener
Battery Ventures to buy Enzo Biochem for $0.70 per share in all cash-deal - MSN
Enzo Biochem to be acquired for $0.70/share in Battery Ventures deal | ENZ SEC FilingForm 8-K - Stock Titan
ENZ to be Acquired for $0.70 Cash in Battery Ventures Deal | ENZ SEC FilingForm DEFA14A - Stock Titan
Enzo Biochem: Fiscal Q3 Earnings Snapshot - New Haven Register
Enzo Biochem Reports Revenue Decline and Net Loss - TipRanks
Enzo Biochem Explores Sale Options as Q3 Revenue Drops 20%, Settles Cyber Incident for $7.5M - Stock Titan
Enzo Biochem Reports Third Quarter Fiscal Year 2025 Results - GlobeNewswire
ENZO BIOCHEM INC SEC 10-Q Report - TradingView
Enzo Biochem (NYSE:ENZ) Earns Hold Rating from Analysts at StockNews.com - Defense World
Enzo Biochem (NYSE:ENZ) Now Covered by Analysts at StockNews.com - Defense World
Deadline to claim up to $10K from Enzo Biochem data breach settlement - Fingerlakes1.com
Press Release Distribution & PR Platform - ACCESS Newswire
Enzo Biochem (NYSE:ENZ) Coverage Initiated at StockNews.com - Defense World
Recent Insider Activity Suggests Potential Gains for Enzo Biochem, Inc (ENZ) - knoxdaily.com
Enzo Biochem Announces Review of Strategic Alternatives - marketscreener.com
Enzo Biochem, Inc (ENZ)’s stock price range in the last year - uspostnews.com
Enzo Biochem, Inc. Announces Review of Strategic - GlobeNewswire
Enzo Biochem Announces Review Of Strategic Alternatives After Receiving Multiple Inquiries Regarding A Potential Transaction - marketscreener.com
Enzo Biochem, Inc. Announces Review of Strategic Alternatives after Receiving Multiple ... - Bluefield Daily Telegraph
Enzo Biochem Launches Strategic Review: Multiple Buyers Eye Global Life Sciences Operations - Stock Titan
Enzo Biochem, Inc. Announces Review of Strategic Alternatives after Receiving Multiple Inquiries Regarding a Potential Transaction - Yahoo Finance
Enzo Biochem transitions to OTCQX market By Investing.com - Investing.com South Africa
Enzo Biochem transitions to OTCQX market - Investing.com
OTC Markets Group welcomes addition of Enzo Biochem to OTCQX - Proactive Investors
OTC Markets Group Welcomes Enzo Biochem, Inc. to OTCQX | OTCM St - GuruFocus
OTC Markets Group Welcomes Enzo Biochem, Inc. to OTCQX | OTCM Stock News - GuruFocus
OTC Markets Group Welcomes Enzo Biochem, Inc. to OTCQX - The Manila Times
Enzo Biochem Makes Strategic Move to OTCQX Market: Cost Savings While Maintaining Investor Access - Stock Titan
The Zacks Analyst Blog AbbVie, The TJX, The Charles Schwab, Enzo Biochem and CVD Equipment - Yahoo Finance
Top Research Reports for AbbVie, TJX & Charles Schwab - Yahoo Finance
Enzo Biochem (NYSE:ENZ) Now Covered by StockNews.com - Defense World
Market Resilience: Enzo Biochem, Inc (ENZ) Finishes Weak at 0.29, Down -8.98 - DWinneX
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Virtu Financial LLC Takes $35,000 Position in Enzo Biochem, Inc. (NYSE:ENZ) - Defense World
Enzo Biochem stock hits 52-week low at $0.33 amid market challenges - Investing.com Australia
Enzo Biochem stock hits 52-week low at $0.33 amid market challenges By Investing.com - Investing.com South Africa
Enzo Biochem to Delist from NYSE, Move to OTCQX - TipRanks
StockNews.com Begins Coverage on Enzo Biochem (NYSE:ENZ) - Defense World
Enzo Biochem to delist from NYSE, move to OTCQX market - Investing.com India
Enzo Biochem to delist from NYSE, move to OTCQX market By Investing.com - Investing.com South Africa
Enzo Biochem to voluntarily delist from NYSE and transfer trading of shares to OTCQX; shares fall - MSN
Enzo Biochem (ENZ) to Voluntarily Delist from NYSE, Move to OTCQ - GuruFocus
Enzo Biochem Inc Stock (ENZ) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.96%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):